Robotic magnetic navigation

Intermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic Technology

Retrieved on: 
Thursday, February 22, 2024
Intermountain West, Robotic magnetic navigation, Intermountain Health, RMN, MD, Intermountain Medical Center, Arrhythmia, Stroke, Risk, Heart failure, Safety, Genesis, Health, Patient, Science, Arrest, Robotics

Intermountain Medical Center is the leading provider of robotic heart rhythm care in Utah and the Intermountain Region.

Key Points: 
  • Intermountain Medical Center is the leading provider of robotic heart rhythm care in Utah and the Intermountain Region.
  • Electrophysiologists at the hospital have treated more than 1,000 patients using advanced robotic technology.
  • “Delivering outstanding patient care using the best technology and science is our primary focus at Intermountain,” said Michael Cutler, MD, cardiac electrophysiologist at Intermountain Medical Center.
  • “We look forward to continuing to support their successful and impactful robotic heart rhythm care program.”

Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients

Retrieved on: 
Tuesday, November 28, 2023
Learning, Risk, Life, Arrest, Physician, Research, Robotics, Heart, Stroke, Robotic magnetic navigation, Arrhythmia, Knowledge, Patient, Safety, Heart failure, RMN, Medical device

Electrophysiologists at Baptist Health Lexington were the first globally to pioneer clinical use of Robotic Magnetic Navigation for the treatment of patients in 2003.

Key Points: 
  • Electrophysiologists at Baptist Health Lexington were the first globally to pioneer clinical use of Robotic Magnetic Navigation for the treatment of patients in 2003.
  • The robotic technology represented an entirely novel way to address heart rhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety.
  • With the unveiling of the Genesis System, Baptist Health Lexington has become the first in Kentucky, and one of the first in the world, to provide the latest advancement in robotic technology to treat cardiac arrhythmias.
  • “We are excited to build upon our leading robotic program and our long legacy of pioneering advanced technologies to advance care,” says Chris Roty, president of Baptist Health Lexington.

Heart Centre Rigshospitalet Enhances Leadership in Patient Care with Adoption of Latest Robotic Technology

Retrieved on: 
Wednesday, September 6, 2023
Partnership, Copenhagen University Hospital, Heart failure, Arrest, Stroke, Genesis, Arrhythmia, Robotic magnetic navigation, Hospital, Patient, Physician, Risk, Rigshospitalet, Health, NYSE, Shahid Gangalal National Heart Centre, Safety, Electrophysiology, Medical device, Nursing, Stereotaxis

The Genesis system is the latest and most advanced robotic technology available for the treatment of heart rhythm disorders.

Key Points: 
  • The Genesis system is the latest and most advanced robotic technology available for the treatment of heart rhythm disorders.
  • Electrophysiologists at The Heart Centre Rigshospitalet were early pioneers, and are global leaders, in the use of advanced robot technology for the treatment of cardiac arrhythmias.
  • Since installation of the first robotic system in 2006, Rigshospitalet physicians have successfully treated over 5,000 patients using Stereotaxis’ robotic technology.
  • “We look forward to continuing a strong collaboration that advances patient care, clinical science, and technology development in electrophysiology.”

Overland Park Regional Medical Center Becomes First U.S. Hospital with Two Stereotaxis Robotic Systems for Arrhythmia Treatment

Retrieved on: 
Wednesday, August 30, 2023
Heart, Heart failure, Arrest, Atrial fibrillation, Stroke, Hope, Electrophysiology, Arrhythmia, BSN, RMN, Robotic magnetic navigation, Ventricular tachycardia, Patient, Physician, Risk, EP, RN, Health, Overland Park Regional Medical Center, RCIS, NYSE, Genesis, Safety, Medical device, MD

OPRMC – part of HCA Midwest Health, Kansas City’s largest healthcare provider – is the only hospital in the U.S. to offer two Stereotaxis Robotic Magnetic Navigation systems for patients receiving minimally invasive cardiac ablation procedures.

Key Points: 
  • OPRMC – part of HCA Midwest Health, Kansas City’s largest healthcare provider – is the only hospital in the U.S. to offer two Stereotaxis Robotic Magnetic Navigation systems for patients receiving minimally invasive cardiac ablation procedures.
  • “Establishing a second robotic electrophysiology lab allows for additional capacity and opportunities to provide the high-quality, compassionate patient care we are known for to the communities we serve,” says Overland Park Regional Medical Center CEO Matt Sogard.
  • “I’ve worked with Dr. Lakkireddy in the EP lab at Overland Park Regional Medical Center since 2018 and had complete confidence in him,” said Mr. Kellogg.
  • “The initial procedures with Genesis went very well,” said Dhanunjaya “DJ” Lakkireddy, MD, Electrophysiologist and Executive Medical Director of Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center.

Advocate Christ Medical Center Extends Leadership in Heart Care with Adoption of Genesis Robotic Technology

Retrieved on: 
Tuesday, May 23, 2023
Partnership, Heart failure, Arrest, Advocate Christ Medical Center, Stroke, Arrhythmia, RMN, Robotic magnetic navigation, Patient, Risk, Cardiology, Robotics, Health, NYSE, Safety, Medical device, Genesis

Advocate Christ Medical Center, a part of Advocate Health, is the leading provider of robotic heart rhythm care in the Midwest.

Key Points: 
  • Advocate Christ Medical Center, a part of Advocate Health, is the leading provider of robotic heart rhythm care in the Midwest.
  • Electrophysiologists at the hospital have treated over 2,000 patients using advanced robotic technology.
  • "At Advocate Christ, we take pride in providing the highest quality care," said Dr. Jeffrey Neiger, Cardiac Electrophysiologist at Advocate Christ Medical Center.
  • "We look forward to working with them in ensuring the best possible heart care is available to the Chicago community."

Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms

Retrieved on: 
Friday, May 19, 2023
Field line, Heart failure, Arrest, Stroke, Medicine, Arrhythmia, Robotic magnetic navigation, Banner University Medical Center Tucson, US, Patient, Physician, Electrophysiology, Risk, Robotics, NYSE, US FDA, Safety, Medical device, Stereotaxis

ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott’s EnSite™ X EP System with Stereotaxis’ Robotic Magnetic Navigation systems.

Key Points: 
  • ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott’s EnSite™ X EP System with Stereotaxis’ Robotic Magnetic Navigation systems.
  • The combination of Abbott’s leading cardiac mapping system with Stereotaxis’ advanced robotic technology brings together highly detailed real-time diagnostic information with the unprecedented precision and stability of robotics during therapy delivery.
  • Technology integration enhances the physician experience, streamlines procedural workflow, and supports the improved treatment of patients with abnormal heart rhythms.
  • Stereotaxis and Abbott have successfully completed integration of their technologies and performed testing demonstrating joint compatibility.

Corewell Health Grows Robotic Program to Treat Heart Rhythm Disorders with Adoption of Stereotaxis’ Genesis System

Retrieved on: 
Tuesday, December 20, 2022
Robotic magnetic navigation, RMN, Partnership, Stroke, Health, Arrhythmia, Arrest, Genesis, Risk, Patient, NYSE, Physician, Safety, Heart failure, Medical device, Stereotaxis

Electrophysiologists at Corewell Health have established a successful robotic cardiac ablation program treating nearly 500 patients using advanced robotic technology.

Key Points: 
  • Electrophysiologists at Corewell Health have established a successful robotic cardiac ablation program treating nearly 500 patients using advanced robotic technology.
  • The hospital is now among the first in the world, and the first in Michigan, to offer the latest in RMN technology with the Genesis system.
  • “Robotics is an integral part of our electrophysiology program at Corewell Health and reflects our ongoing commitment of being at the forefront of cardiovascular care,” said Dr. Musa Dahu, cardiac electrophysiologist at Corewell Health.
  • “We look forward to working with Corewell Health to extend its leadership in arrhythmia care in Grand Rapids.”

Stereotaxis Receives St. Louis Mayor’s Innovation Award for 2022

Retrieved on: 
Monday, October 3, 2022
GLOBE, Disaster, Physician, Robotics, Pandemic, Technology, Intelligence, Research, Chicago Innovation Awards, Health, Arrhythmia, CEO, Robotic magnetic navigation, U.S. Securities and Exchange Commission, Safety, NYSE, Security (finance), Patient, Globe Building, Forward-looking statement, Company, Medicine, Medical device, Pharmaceutical industry, Stereotaxis

ST. LOUIS, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it was awarded the 2022 Innovation Award from the Office of the Mayor of St. Louis, Tishaura O. Jones.

Key Points: 
  • ST. LOUIS, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it was awarded the 2022 Innovation Award from the Office of the Mayor of St. Louis, Tishaura O. Jones.
  • In recent years, Stereotaxis significantly increased its investment in innovation, and the company spends over $10 million annually on research and development activities.
  • The guiding principles motivating all of Stereotaxis innovation efforts are to improve patient care, enhance the physician experience, and increase broad accessibility and affordability of robotics.
  • Earlier this year, Stereotaxis opened its 45,000-square-foot global headquarters facility in downtown St. Louis.

Overland Park Regional Medical Center Extends Leadership in Robotic Treatment of Heart Rhythm Disorders with Plans for Second Stereotaxis System

Retrieved on: 
Tuesday, September 13, 2022
Disaster, Safety, Robotic magnetic navigation, Risk, NYSE, Arrest, Company, Health, Arrhythmia, Partnership, Heart failure, Stroke, Pandemic, Forward-looking statement, U.S. Securities and Exchange Commission, Patient, Intelligence, Physician, CEO, Technology, Leadership, Security (finance), GLOBE, Medical device, Stereotaxis

ST. LOUIS, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that Overland Park Regional Medical Center (OPRMC) is establishing its second robotic program for the treatment of heart rhythm disorders.

Key Points: 
  • ST. LOUIS, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that Overland Park Regional Medical Center (OPRMC) is establishing its second robotic program for the treatment of heart rhythm disorders.
  • OPRMC, a part of HCA Midwest Health, first established a robotic heart rhythm care program in 2019.
  • The Kansas City Heart Rhythm Institute at OPRMC has successfully built a reputation for leadership in clinical care and healthcare research.
  • Our robotic electrophysiology program has been an important pillar in that success, said Dr. Dhanunjaya Lakkireddy, Executive Medical Director for the Kansas City Heart Rhythm Institute.

Journal of Atrial Fibrillation & Electrophysiology Publishes Special Issue Dedicated to Robotics in EP

Retrieved on: 
Monday, June 6, 2022
Atrial fibrillation, RMN, Supraventricular tachycardia, Company, Stroke, Journal, Survival, Arrhythmia, Forward-looking statement, CEO, Security (finance), Society, U.S. Securities and Exchange Commission, Motivation, Tachycardia, Heart failure, Intelligence, Disaster, Physician, Health, Robotics, Patient, Publication, Hospital, GLOBE, Technology, Risk, NYSE, Pandemic, Adoption, Robotic magnetic navigation, Efficiency, Heart, Education, Safety, University, Automation, Medical device, Stereotaxis, Electrophysiology

Physicians from 20 hospitals and universities throughout North America, Europe and Asia contributed to the sixteen publications in the Robotics Special Issue.

Key Points: 
  • Physicians from 20 hospitals and universities throughout North America, Europe and Asia contributed to the sixteen publications in the Robotics Special Issue.
  • The publications cover a wide range of topics including:
    Reviews of clinical outcomes from large subsets of patients with atrial fibrillation, ventricular tachycardias and supraventricular tachycardias
    Robotics represents increasingly important technology for the field of electrophysiology, said Dr. Andrea Natale, Editor-in-Chief of the Journal of Atrial Fibrillation & Electrophysiology.
  • We are delighted to collaborate with the Society for Cardiac Robotic Navigation on this special issue and to contribute to the advancement of clinical science and awareness.
  • The Journal of Atrial Fibrillation & Electrophysiology was founded in 2008.